Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

Stopped early

Conditions studied: Turner Syndrome, Idiopathic Short Stature

In brief

Growth hormone treatment improves body fat distribution but also causes insulin resistance. Scientists have recently linked insulin resistance with special stores of fat in the muscles, which can be measured by magnetic resonance imaging (MRI). The researchers hypothesize that growth hormone will paradoxically reverse the linkage between muscle fat stores and insulin resistance. To assess this association and to investigate the cause(s), the researchers will measure muscle fat stores during growth hormone treatment. Other parameters linked to insulin resistance (glucose tolerance, blood markers, and body composition) will also be assessed. This study may lead to improved strategies for monitoring growth hormone therapy.

Key facts

Study ID
NCT00121875
Run by
Massachusetts General Hospital
People needed
1
Starts
2005-06-01
Expected to finish
2008-12-01
Last updated by the study team
2009-09-29

Who can join

Age: 7 and older, up to 14. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.